智通财经APP讯，水发兴业能源(00750)发布公告，有关发行2025年公司债券，已成功完成向专业投资者 发行所有债券，悉数动用不超过人民币15亿元的注册发行规模。债券期限为五年，票面利率介于3.03% 至3.45%之间。于第三年末，公司将有权行使调整票面利率选择权，而债券持有人将有权行使回售选择 权。 ...

水发兴业能源(00750)发布公告，有关发行2025年公司债券，已成功完成向专业投资者发行所有债券， 悉数动用不超过人民币15亿元的注册发行规模。债券期限为五年，票面利率介于3.03%至3.45%之间。 于第三年末，公司将有权行使调整票面利率选择权，而债券持有人将有权行使回售选择权。 ...

Core Viewpoint - China Resources Pharmaceutical (03320) has successfully completed the public issuance of the second phase of its 2025 corporate bonds, raising a total principal amount of RMB 1.1 billion with a maturity of 3 years and an annual coupon rate of 1.78% [1] Group 1 - The total principal amount of the second phase of the 2025 corporate bonds issued is RMB 1.1 billion [1] - The bonds have a maturity period of 3 years and a coupon rate of 1.78% [1] - The net proceeds from the bond issuance will be used for productive expenditures, including debt repayment, working capital supplementation, project development and operational expenses, investments related to technological innovation, and other uses compliant with applicable laws and regulations [1]

Core Viewpoint - China Resources Pharmaceutical (03320.HK) has successfully completed the public issuance of the second phase of its 2025 corporate bonds, raising a total principal amount of RMB 1.1 billion with a three-year term and an annual coupon rate of 1.78% [1] Group 1 - The total principal amount of the second phase of the 2025 corporate bonds issued is RMB 1.1 billion [1] - The bonds have a maturity period of three years and an annual interest rate of 1.78% [1] - The net proceeds from the bond issuance will be used for productive expenditures, including debt repayment, working capital supplementation, project development and operational expenses, investments related to technological innovation, and other uses compliant with applicable laws and regulations [1]

Core Viewpoint - China Resources Pharmaceutical (03320) has issued the first phase of its 2025 corporate bonds totaling RMB 1.1 billion, with a three-year term and an annual coupon rate of 1.82% [1] Summary by Relevant Categories Financial Details - The total principal amount of the issued bonds is RMB 1.1 billion [1] - The bonds have a maturity period of three years [1] - The coupon rate for the bonds is set at 1.82% per annum [1] Use of Proceeds - The net proceeds from the bond issuance will be utilized for productive expenditures [1] - Specific uses include debt repayment, working capital supplementation, project development and operational expenses, investments related to technological innovation, and other purposes compliant with applicable laws and regulations [1]

Core Viewpoint - China Resources Pharmaceutical (03320) has issued the first phase of its 2025 corporate bonds totaling RMB 1.1 billion, with a three-year term and an annual coupon rate of 1.82% [1] Summary by Categories Financial Details - The total principal amount of the issued bonds is RMB 1.1 billion [1] - The bonds have a maturity period of three years [1] - The coupon rate for the bonds is set at 1.82% per annum [1] Use of Proceeds - The net proceeds from the bond issuance will be utilized for productive expenditures [1] - Specific uses include debt repayment, working capital supplementation, project development and operational expenses, investments related to technological innovation, and other purposes compliant with applicable laws and regulations [1]

Group 1 - The company plans to publicly issue bonds with a face value of 100 yuan, totaling no more than 2 billion yuan [1] - The bond term will not exceed 5 years, with specific types and term structures to be determined based on market conditions [1] - The raised funds will be used for supplementing working capital, repaying interest-bearing liabilities, purchasing fixed assets, or other compliant purposes [1]